NeuroPace (NPCE)
(Delayed Data from NSDQ)
$13.39 USD
+0.40 (3.08%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $13.38 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Income Statements
Fiscal Year end for NeuroPace, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 65 | 46 | 45 | 41 | 37 |
Cost Of Goods | 17 | 13 | 12 | 11 | 11 |
Gross Profit | 48 | 32 | 33 | 30 | 26 |
Selling & Adminstrative & Depr. & Amort Expenses | 75 | 73 | 57 | 43 | 48 |
Income After Depreciation & Amortization | -27 | -41 | -24 | -13 | -22 |
Non-Operating Income | 3 | 1 | -5 | 0 | 2 |
Interest Expense | 9 | 8 | 7 | 11 | 9 |
Pretax Income | -33 | -47 | -36 | -24 | -30 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -33 | -47 | -36 | -24 | -30 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -33 | -47 | -36 | -24 | -30 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -27 | -40 | -23 | -9 | -19 |
Depreciation & Amortization (Cash Flow) | 0 | 1 | 1 | 4 | 3 |
Income After Depreciation & Amortization | -27 | -41 | -24 | -13 | -22 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 25.85 | 24.60 | 16.61 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.27 | -1.91 | -2.17 | NA | NA |
Diluted Net EPS (GAAP) | -1.27 | -1.91 | -2.17 | -117.85 | NA |
Fiscal Year end for NeuroPace, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 18.01 | 16.43 | 16.51 | 14.47 |
Cost Of Goods | NA | 4.47 | 4.19 | 4.54 | 4.10 |
Gross Profit | NA | 13.54 | 12.23 | 11.97 | 10.37 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 18.60 | 18.19 | 19.82 | 18.69 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.06 | -5.96 | -7.85 | -8.32 |
Non-Operating Income | NA | 1.09 | 0.88 | 0.86 | -0.09 |
Interest Expense | NA | 2.24 | 2.19 | 2.13 | 1.97 |
Pretax Income | NA | -6.20 | -7.26 | -9.12 | -10.38 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -6.20 | -7.26 | -9.12 | -10.38 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -6.20 | -7.26 | -9.12 | -10.38 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 26.80 | 26.02 | 25.47 | 25.10 |
Diluted EPS Before Non-Recurring Items | NA | -0.23 | -0.28 | -0.36 | -0.41 |
Diluted Net EPS (GAAP) | NA | -0.22 | -0.28 | -0.36 | -0.41 |